China
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
24.16%
|
Dec. 31, 2023 | USD 32.04 | -0.79% |
|
China |
|
2 |
23.58%
|
Dec. 31, 2023 | USD 11.15 | 0.89% |
|
China |
|
3 |
22.09%
|
Dec. 31, 2023 | USD 7.81 | 1.73% |
|
China |
|
4 |
20.75%
|
Dec. 31, 2023 | USD 52.19 | 2.06% |
|
China |
|
5 |
20.11%
|
Dec. 31, 2023 | USD 8.53 | -1.46% |
|
China |
|
6 |
18.12%
|
Dec. 31, 2023 | USD 2.77 | -0.49% |
|
China |
|
7 |
17.46%
|
Dec. 31, 2023 | USD 4.96 | 0.66% |
|
China |
|
8 |
16.26%
|
Dec. 31, 2023 | USD 2.46 | -0.48% |
|
China |
|
9 |
16.07%
|
Dec. 31, 2023 | USD 3.32 | -1.00% |
|
China |
|
10 |
15.56%
|
Dec. 31, 2023 | USD 3.80 | 1.71% |
|
China |
|
11 |
15.03%
|
Dec. 31, 2023 | USD 1.06 | -0.48% |
|
China |
|
12 |
15.00%
|
Dec. 31, 2023 | USD 4.94 | 2.25% |
|
China |
|
13 |
14.72%
|
Dec. 31, 2023 | USD 9.42 | 1.19% |
|
China |
|
14 |
14.24%
|
Dec. 31, 2023 | USD 1.01 | 0.62% |
|
China |
|
15 |
13.51%
|
Dec. 31, 2023 | USD 2.87 | 0.00% |
|
China |
|
16 |
13.04%
|
Dec. 31, 2023 | USD 7.19 | 0.25% |
|
China |
|
17 |
12.83%
|
Dec. 31, 2023 | USD 2.14 | -0.61% |
|
China |
|
18 |
12.69%
|
Dec. 31, 2023 | USD 0.57 | -0.69% |
|
China |
|
19 |
12.51%
|
Dec. 31, 2023 | USD 5.83 | 0.29% |
|
China |
|
20 |
12.25%
|
Dec. 31, 2023 | USD 2.66 | 0.85% |
|
China |
|
21 |
12.11%
|
Dec. 31, 2023 | USD 2.68 | -1.51% |
|
China |
|
22 |
12.10%
|
Dec. 31, 2023 | USD 7.07 | -1.23% |
|
China |
|
23 |
12.05%
|
Dec. 31, 2023 | USD 3.86 | -2.36% |
|
China |
|
24 |
12.04%
|
Dec. 31, 2023 | USD 1.35 | 1.98% |
|
China |
|
25 |
11.91%
|
Dec. 31, 2023 | USD 2.99 | 0.60% |
|
China |
|
26 |
11.82%
|
Dec. 31, 2023 | USD 0.82 | 2.23% |
|
China |
|
27 |
11.60%
|
Dec. 31, 2023 | USD 14.52 | -1.12% |
|
China |
|
28 |
11.48%
|
Dec. 31, 2023 | USD 10.27 | -0.41% |
|
China |
|
29 |
11.06%
|
Dec. 31, 2023 | USD 9.61 | -0.14% |
|
China |
|
30 |
10.76%
|
Dec. 31, 2023 | USD 2.35 | 0.02% |
|
China |
|
31 |
10.70%
|
Dec. 31, 2023 | USD 1.86 | 0.20% |
|
China |
|
32 |
10.56%
|
Dec. 31, 2023 | USD 2.03 | -0.16% |
|
China |
|
33 |
10.54%
|
Dec. 31, 2023 | USD 5.53 | -0.19% |
|
China |
|
34 |
10.27%
|
Dec. 31, 2023 | USD 4.92 | -0.07% |
|
China |
|
35 |
10.17%
|
Dec. 31, 2023 | USD 1.05 | 2.05% |
|
China |
|
36 |
10.13%
|
Dec. 31, 2023 | USD 1.06 | -1.57% |
|
China |
|
37 |
10.12%
|
Dec. 31, 2023 | USD 1.82 | 0.98% |
|
China |
|
38 |
10.08%
|
Dec. 31, 2023 | USD 1.10 | -0.84% |
|
China |
|
39 |
10.02%
|
Dec. 31, 2023 | USD 1.77 | 0.45% |
|
China |
|
40 |
10.00%
|
Dec. 31, 2023 | USD 1.51 | -1.09% |
|
China |
|
41 |
9.98%
|
Dec. 31, 2023 | USD 0.47 | 3.66% |
|
China |
|
42 |
9.93%
|
Dec. 31, 2023 | USD 3.06 | -1.56% |
|
China |
|
43 |
9.92%
|
Dec. 31, 2023 | USD 2.28 | 1.94% |
|
China |
|
44 |
9.92%
|
Dec. 31, 2023 | USD 4.81 | -0.80% |
|
China |
|
45 |
9.91%
|
Dec. 31, 2023 | USD 3.07 | 0.63% |
|
China |
|
46 |
9.83%
|
Dec. 31, 2023 | USD 6.16 | -0.07% |
|
China |
|
47 |
9.65%
|
Dec. 31, 2023 | USD 4.21 | 1.60% |
|
China |
|
48 |
9.52%
|
Dec. 31, 2023 | USD 1.80 | -0.70% |
|
China |
|
49 |
9.52%
|
Dec. 31, 2023 | USD 0.30 | -0.02% |
|
China |
|
50 |
9.33%
|
Dec. 31, 2023 | USD 2.15 | -0.48% |
|
China |
The Healthcare company in China with the highest Return on Assets (ROA) is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen Stock Exchange: 300760.SZ) at 24.16%.
The Healthcare company in China with the lowest Return on Assets (ROA) is Burning Rock Biotech Limited (NasdaqGM: BNR) at -62.85%.
The top 10 Healthcare companies in China by Return on Assets (ROA) are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Akeso, Inc., APT Medical Inc., Shenzhen New Industries Biomedical Engineering Co., Ltd., Yantai Zhenghai Biotechnology Co., Ltd., Tibet Rhodiola Pharmaceutical Holding Co., Sunflower Pharmaceutical Group Co.,Ltd, Chongqing Zhifei Biological Products Co., Ltd. and Hubei Jumpcan Pharmaceutical Co., Ltd..
The bottom 10 Healthcare companies in China by Return on Assets (ROA) are Burning Rock Biotech Limited, I-Mab, Connect Biopharma Holdings Limited, Genor Biopharma Holdings Limited, ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Besunyen Holdings Company Limited, Ascentage Pharma Group International, Shenzhen Division Co.,Ltd., JW (Cayman) Therapeutics Co. Ltd and Zai Lab Limited.